Caution Advised When Using Hormone Therapy For Prostate Cancer

Main Category: Prostate / Prostate Cancer
Also Included In: Endocrinology;  Cardiovascular / Cardiology;  Clinical Trials / Drug Trials
Article Date: 06 Apr 2008 - 0:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

4.57 (7 votes)

Healthcare Prof:4 stars

4 (1 votes)


In men with localized but aggressive prostate cancer, the combination of testosterone-lowering therapy and radiation improves survival substantially more than radiation therapy alone. But testosterone-lowering therapy isn't so hot for the heart, reports the April issue of the Harvard Heart Letter. Low testosterone can increase harmful LDL cholesterol, blood sugar, blood pressure, and weight. It can also make arteries stiffer, promote formation of artery-clogging plaque, and allow blood clots to form more readily.

Preliminary results show that testosterone-lowering therapy is associated with more diabetes, more heart disease, and earlier heart attacks. However, this hormone therapy does have a significant benefit in curing prostate cancer. For instance, one study of patients with localized but unfavorable prostate cancer found that about 90% of otherwise healthy men who underwent radiation and hormone therapy were still alive after eight years, compared with about 65% of those who had only radiation therapy. The reverse was true among those with moderate or severe health problems in addition to their prostate cancer: only about 25% of those who underwent the combination were still alive, compared with 55% of those who had radiation alone.

These findings don't mean hormone therapy should be off limits. Quite the contrary suppressing testosterone is a life-prolonging addition to radiation therapy for men with locally advanced prostate cancer or cancer that has spread. The Harvard Heart Letter suggests that hormone therapy be used with caution in men who have had a heart attack or who are at high risk for cardiovascular disease.

Harvard Heart Letter
Harvard Health Publications Harvard Medical School 10 Shattuck St., Ste. 612
Cambridge, MA 02115
United States
http://www.health.harvard.edu

Article adapted by Medical News Today from original press release.
Visit our prostate / prostate cancer section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Harvard Heart Letter. "Caution Advised When Using Hormone Therapy For Prostate Cancer." Medical News Today. MediLexicon, Intl., 6 Apr. 2008. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/102932.php>

APA
Harvard Heart Letter. (2008, April 6). "Caution Advised When Using Hormone Therapy For Prostate Cancer." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/102932.php.

Please note: If no author information is provided, the source is cited instead.


Prostate / Prostate Cancer

Most Popular Articles



Follow Our Prostate News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Prostate / Prostate Cancer Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »